简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Guotai CSI All Share Investment Banking & Brokerage ETF
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 66.77 million on Aug 11, ranked top among stock ETFs
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-08-12
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 60.09 million on Aug 5, ranked top among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-08-06
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 34.16 million on Jul 27, ranked first among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-07-28
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 64.85 million, ranked first among comparable funds-20260724
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
2026-07-27
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 25.52 million on Jul 21, ranked top among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-07-22
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 129.73 million on jul 13, the last 6 days with a total inflow of CNY 480.04 million
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-07-14
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 33.12 million, ranked in the top 2 among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-07-13
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 87.79 million on jul 8, ranked top among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-07-09
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 151.63 million on jun 26, ranked top among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-06-29
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 69 million, ranked first among comparable funds-20260513
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
2026-05-14
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 53.57 million, ranked first among comparable funds-20260511
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
2026-05-12
ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 102.09 million, ranked first among comparable funds
Tags:
Guotai CSI All Share Investment Banking & Brokerage ETF
512880.SH
NewTimeSpace
2026-05-08
Featured News
Finance
China Aluminum Cans (06898.HK): H1 Net Profit Expected to Rise Over 30% Year-on-Year
Finance
CSPC Pharmaceutical Group (01093.HK): Receives US$30 Million Upfront Payment Under siRNA Collaboration Agreement with AstraZeneca
Finance
New City Development Group (00456.HK): Appointment of Li Yang as Co-Chief Executive Officer
Finance
ORIENTAL EXPL (00430.HK): Expects Interim Profit to Fall to Approximately HK$ 3,000,000-3,200,000 on Lower Rental Income
Finance
V.S. INT'L (01002.HK): Expects Interim Profit of USD 3,000,000-4,000,000, Markedly Up from the Same Period Last Year
Finance
HENGRUI PHARMA (01276.HK): SHR-7590 Injection Receives Drug Clinical Trial Approval Notice for Ulcerative Colitis and Crohn's Disease
Finance
CAPINFO (01075.HK): Expects Interim Results to Swing to Loss of Approximately RMB 30-50 Million
Finance
CH TIANBAO GP (01427.HK): Expects Interim Net Loss to Widen to RMB 60-70 Million on Reduced Revenue
Finance
MULTIFIELD INTL (00898.HK): Expects Interim Profit to Fall to Approximately HK$ 100-120 Million on Lower Fair Value Gains on Financial Assets
Finance
HENGRUI PHARMA (01276.HK): HRS-4729 Injection Approved for Phase II Clinical Trial in Type 2 Diabetes
Scan QR Code
Download App